The first mass immunization program against Covid-19 in the Western world will begin in the UK on Tuesday, December 8th. The first vaccines will be given to the elderly and carers.
For Britain, this program and the results expected from it are particularly important, as Britain has the highest number of Covid-19 victims in Europe, with over 60,000.
The British will launch a Covid-19 vaccination programUģis Lībietis00:00 / 01:01
—
The first vaccines developed by Pfizer / BioNTech to be used in the UK were delivered to the UK over the weekend. received the green light December 2.
About 800,000 vaccines have been imported from Belgium and vaccination points have been set up in 50 hospitals. Patients over 80 years of age are expected to receive the new vaccine first.
A statement from the British National Health Service emphasized that negotiations were also under way with nursing homes to apply for vaccination for their staff. However, it is not yet reported whether the residents of the care homes will be vaccinated initially.
Starting on December 14, doctors will also start vaccinating the general public on a small scale, and patients will have to be revaccinated after 21 days after receiving the first dose.
Other governments and health agencies around the world are expected to carefully evaluate the British vaccination program, which could take months to assess successes and failures, and to adjust their plans accordingly.
CONTEXT:
US pharmaceutical giant Pfizer and German company BioNTech have applied for conditional approval of their Covid-19 vaccine to the European Medicines Agency, which will convene a meeting on December 29 to decide whether there is sufficient data on the development of Pfizer and BioNTech. Safety and efficacy of Covid-19 vaccine.
The agency also said that a decision could be made on January 12 to approve the vaccine against the new coronavir developed by the US pharmaceutical company “Moderna”.
Three Covid-19 vaccine developers are currently trying to get their vaccines approved for use in December. „Pfizer” a „BioNTech”, “Modern”, as well as „AstraZeneca” and Oxford University. At the end of November “Moderna” submitted application for registration with the European Medicines Agency, as well as with the responsible authorities in the USA and other countries.
The European Union has already concluded agreements with companies “Modern”, “Pfizer” a “BioNTech”, AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica and CureVac for the purchase of their Covid-19 vaccines when available
–
Highlight text and press Ctrl+Enterto send the text to be edited!
Highlight text and press Report a bug buttons to send the text to be edited!
–
–
